- Home
- NVVEW vs ZLAB Comparison
NVVEW vs ZLAB Comparison
Compare NVVEW & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVVEW | ZLAB |
|---|---|---|
| Founded | N/A | 2013 |
| Country | China | China |
| Employees | 12 | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 2.2B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | NVVEW | ZLAB |
|---|---|---|
| Price | $0.02 | $19.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $57.22 |
| AVG Volume (30 Days) | N/A | ★ 849.1K |
| Earning Date | N/A | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $441,629,000.00 |
| Revenue This Year | N/A | $30.20 |
| Revenue Next Year | N/A | $34.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.14 |
| 52 Week Low | N/A | $19.40 |
| 52 Week High | N/A | $44.34 |
Technical Indicators
Market Signals| Indicator | NVVEW | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 46.22 | 25.39 |
| Support Level | $0.02 | $19.40 |
| Resistance Level | $0.02 | $20.47 |
| Average True Range (ATR) | 0.00 | 0.54 |
| MACD | -0.00 | 0.25 |
| Stochastic Oscillator | 20.78 | 8.06 |
Price Performance
Historical ComparisonAbout NVVEW Nuvve Holding Corp. Warrant
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.